Joshua Mondschein to Disease-Free Survival
This is a "connection" page, showing publications Joshua Mondschein has written about Disease-Free Survival.
Connection Strength
0.056
-
A phase I trial of concurrent sorafenib and stereotactic radiosurgery for patients with brain metastases. J Neurooncol. 2017 Jun; 133(2):435-442.
Score: 0.034
-
Long-term follow-up of a Phase II trial of high-dose radiation with concurrent 5-fluorouracil and cisplatin in patients with anal cancer (ECOG E4292). Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e607-13.
Score: 0.022